Cargando…

Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine

BACKGROUND: Human Papillomavirus type 16 (HPV16) has been associated with a subset of head and neck cancers. Two HPV encoded oncogenic proteins, E6 and E7, are important for the malignant progression of HPV-associated cancers. A spontaneous HPV16 E6/E7-expressing oral tumor model in human HLA-A2 (AA...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Ssu-Hsueh, Liu, Li, Peng, Shiwen, Kim, Jinhwi, Ferrall, Louise, Hung, Chien-Fu, Wu, T. -C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436567/
https://www.ncbi.nlm.nih.gov/pubmed/34517865
http://dx.doi.org/10.1186/s12929-021-00759-x
_version_ 1783752018452545536
author Tseng, Ssu-Hsueh
Liu, Li
Peng, Shiwen
Kim, Jinhwi
Ferrall, Louise
Hung, Chien-Fu
Wu, T. -C.
author_facet Tseng, Ssu-Hsueh
Liu, Li
Peng, Shiwen
Kim, Jinhwi
Ferrall, Louise
Hung, Chien-Fu
Wu, T. -C.
author_sort Tseng, Ssu-Hsueh
collection PubMed
description BACKGROUND: Human Papillomavirus type 16 (HPV16) has been associated with a subset of head and neck cancers. Two HPV encoded oncogenic proteins, E6 and E7, are important for the malignant progression of HPV-associated cancers. A spontaneous HPV16 E6/E7-expressing oral tumor model in human HLA-A2 (AAD) transgenic mice will be important for the development of therapeutic HPV vaccines for the control of HPV-associated head and neck cancers. METHODS: In the current studies, we characterized the HLA-A2 restricted HPV16 E7-specific CD8 + T cell mediated immune responses in the HLA-A2 (AAD) transgenic mice using a therapeutic naked DNA vaccine encoding calreticulin (CRT) linked to a mutated E7(N53S). We also employed oncogenic DNA plasmids that encoded HPV16E6/E7/Luc, NRas(G12V), and sleeping beauty transposase for the transfection into the submucosal of oral cavity of the transgenic mice with electroporation to create a spontaneous oral tumor. Furthermore, we characterized the therapeutic antitumor effects of CRT/E7(N53S) DNA vaccine using the spontaneous HPV16 E6/E7-expressing oral tumor model in HLA-A2 (AAD) transgenic mice. RESULTS: We found that CRT/E7(N53S) DNA vaccine primarily generated human HPV16 E7 peptide (aa11-20) specific CD8 + T cells, as compared to the wild-type CRT/E7 vaccine, which primarily generated murine H-2D(b) restricted E7 peptide (aa49-57) specific CD8 + T cell responses. We also observed transfection of the oncogenic DNA plasmids with electroporation generated spontaneous oral tumor in all of the injected mice. Additionally, treatment with CRT/E7(N53S) DNA vaccine intramuscularly followed by electroporation resulted in significant antitumor effects against the spontaneous HPV16 E6/E7-expressing oral tumors in HLA-A2 (AAD) transgenic mice. CONCLUSIONS: Taken together, the data indicated that the combination of HPV16 E6/E7-expressing DNA, NRas(G12V) DNA and DNA encoding sleeping beauty transposase is able to generate spontaneous oral tumor in HLA-A2 (AAD) transgenic mice, which can be successfully controlled by treatment with CRT/E7(N53S) DNA vaccine. The translational potential of our studies are discussed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12929-021-00759-x.
format Online
Article
Text
id pubmed-8436567
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84365672021-09-13 Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine Tseng, Ssu-Hsueh Liu, Li Peng, Shiwen Kim, Jinhwi Ferrall, Louise Hung, Chien-Fu Wu, T. -C. J Biomed Sci Research BACKGROUND: Human Papillomavirus type 16 (HPV16) has been associated with a subset of head and neck cancers. Two HPV encoded oncogenic proteins, E6 and E7, are important for the malignant progression of HPV-associated cancers. A spontaneous HPV16 E6/E7-expressing oral tumor model in human HLA-A2 (AAD) transgenic mice will be important for the development of therapeutic HPV vaccines for the control of HPV-associated head and neck cancers. METHODS: In the current studies, we characterized the HLA-A2 restricted HPV16 E7-specific CD8 + T cell mediated immune responses in the HLA-A2 (AAD) transgenic mice using a therapeutic naked DNA vaccine encoding calreticulin (CRT) linked to a mutated E7(N53S). We also employed oncogenic DNA plasmids that encoded HPV16E6/E7/Luc, NRas(G12V), and sleeping beauty transposase for the transfection into the submucosal of oral cavity of the transgenic mice with electroporation to create a spontaneous oral tumor. Furthermore, we characterized the therapeutic antitumor effects of CRT/E7(N53S) DNA vaccine using the spontaneous HPV16 E6/E7-expressing oral tumor model in HLA-A2 (AAD) transgenic mice. RESULTS: We found that CRT/E7(N53S) DNA vaccine primarily generated human HPV16 E7 peptide (aa11-20) specific CD8 + T cells, as compared to the wild-type CRT/E7 vaccine, which primarily generated murine H-2D(b) restricted E7 peptide (aa49-57) specific CD8 + T cell responses. We also observed transfection of the oncogenic DNA plasmids with electroporation generated spontaneous oral tumor in all of the injected mice. Additionally, treatment with CRT/E7(N53S) DNA vaccine intramuscularly followed by electroporation resulted in significant antitumor effects against the spontaneous HPV16 E6/E7-expressing oral tumors in HLA-A2 (AAD) transgenic mice. CONCLUSIONS: Taken together, the data indicated that the combination of HPV16 E6/E7-expressing DNA, NRas(G12V) DNA and DNA encoding sleeping beauty transposase is able to generate spontaneous oral tumor in HLA-A2 (AAD) transgenic mice, which can be successfully controlled by treatment with CRT/E7(N53S) DNA vaccine. The translational potential of our studies are discussed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12929-021-00759-x. BioMed Central 2021-09-13 /pmc/articles/PMC8436567/ /pubmed/34517865 http://dx.doi.org/10.1186/s12929-021-00759-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Tseng, Ssu-Hsueh
Liu, Li
Peng, Shiwen
Kim, Jinhwi
Ferrall, Louise
Hung, Chien-Fu
Wu, T. -C.
Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine
title Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine
title_full Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine
title_fullStr Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine
title_full_unstemmed Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine
title_short Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine
title_sort control of spontaneous hpv16 e6/e7 expressing oral cancer in hla-a2 (aad) transgenic mice with therapeutic hpv dna vaccine
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436567/
https://www.ncbi.nlm.nih.gov/pubmed/34517865
http://dx.doi.org/10.1186/s12929-021-00759-x
work_keys_str_mv AT tsengssuhsueh controlofspontaneoushpv16e6e7expressingoralcancerinhlaa2aadtransgenicmicewiththerapeutichpvdnavaccine
AT liuli controlofspontaneoushpv16e6e7expressingoralcancerinhlaa2aadtransgenicmicewiththerapeutichpvdnavaccine
AT pengshiwen controlofspontaneoushpv16e6e7expressingoralcancerinhlaa2aadtransgenicmicewiththerapeutichpvdnavaccine
AT kimjinhwi controlofspontaneoushpv16e6e7expressingoralcancerinhlaa2aadtransgenicmicewiththerapeutichpvdnavaccine
AT ferralllouise controlofspontaneoushpv16e6e7expressingoralcancerinhlaa2aadtransgenicmicewiththerapeutichpvdnavaccine
AT hungchienfu controlofspontaneoushpv16e6e7expressingoralcancerinhlaa2aadtransgenicmicewiththerapeutichpvdnavaccine
AT wutc controlofspontaneoushpv16e6e7expressingoralcancerinhlaa2aadtransgenicmicewiththerapeutichpvdnavaccine